About Pseudomonas aeruginosa

For Everyone

Key points

  • Pseudomonas aeruginosa (P. aeruginosa) infections typically occur in healthcare settings.
  • Good hand hygiene and infection prevention and control can help reduce the risk of infection.
  • P. aeruginosa can be resistant to antibiotics, making these infections difficult to treat.

Overview

Pseudomonas is a group of bacteria commonly found in the environment, like in soil and water. The most common type causing infections among humans is Pseudomonas aeruginosa.

P. aeruginosa can cause infections in the blood, lungs (pneumonia), urinary tract, or other parts of the body after surgery.

Antimicrobial resistance

Some types are resistant to nearly all antibiotics, including carbapenems, known as multidrug-resistant (MDR) P. aeruginosa. In 2023, MDR P. aeruginosa caused an estimated 18,939 infections among hospitalized patients and 1,588 estimated deaths in the United States.1

At-risk populations

Patients in healthcare settings are at highest risk, especially those who:

  • Are on breathing machines (ventilators).
  • Have devices such as catheters.
  • Have open wounds from surgery or burns.

How it spreads

  • Contact with contaminated surfaces or equipment.
  • Exposure in the soil or water.
  • Person-to-person contact, like from contaminated hands.

Reducing risk

Patients and caregivers

  • Keep their hands clean, particularly before and after caring for wounds or touching a medical device.
  • Remind people (including healthcare providers) to clean their hands before touching the patient or handling medical devices.
  • Allow healthcare staff to clean their room daily when in a healthcare setting.

Healthcare settings

Testing

To determine if someone has a P. aeruginosa infection, healthcare providers will send a specimen to the laboratory for antimicrobial susceptibility testing. CDC provides data that can be used for setting breakpoints for interpretation of antimicrobial susceptibility testing.

Treatment and recovery

Treatment generally includes antibiotics. Unfortunately, treatment options are limited for MDR P. aeruginosa.

What CDC is doing

Content Source
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
About this page
Published: May 15, 2024
Updated: June 12, 2025

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: June 10, 2025

The information on this page was last reviewed by subject matter experts to ensure accuracy.